Programme: Tuesday 8 November 2006

Mon 7 Nov | Tues 8 Nov | Wed 9 Nov | Attended Posters

Download Programme (pdf) (138kb)

09.00 – 10.00		Wolfson Theatre
		Plenary Lecture: Society for Endocrinology Medal Lecture
		Chair: Bloom S (London)
	S3	The evolution of primary aldosteronism
		Connell J (Glasgow)
10.00 – 10.30		Osler/Long Room
		Coffee
10.30 – 12.30		Wolfson Theatre
		Symposium 3:
		The placenta as an endocrine organ
		Chair: Westwood M (Manchester)
	S13	Peri/pre-implantation paracrinology
		Jabbour H (Edinburgh)
	S14	Paracrinology of the placenta
		Petraglia F (Siena, Italy)
	S15	Human trophoblast syncytialisation: a cornerstone of placental function
		Linton E (Oxford)
	S16	Foeto-placental 11b-hydroxysteroid dehydrogenase Type 2 and glucocorticoid programming
		Seckl J (Edinburgh)
10.30 – 12.30		Seligman Theatre
		Oral Communication 2 Thyroid and pituitary
		Chair: Gittoes N (Birmingham)
	OC9	Association of the thyrotrophin receptor gene (TSHR) with Graves' disease: evidence from independent UK population based case control and family studies
		Brand OJ, Heward JM, Brix T, Carr-Smith JD, Connell JM, Hegedus L, Hunt PJ, Robinson BG, Wass JAH, Wiersinga WM, Franklyn JA, Weetman A, Gough SCL
	OC10	Treatment of subclinical hypothyroidism with L-thyroxine improves endothelial function due to increase in free T4 levels
		Razvi S, Oates CP, Weaver JU
	OC11	Mortality and vascular outcomes in the thyroid population: an observational study comparing relative levels of mortality and morbidity using the record linkage of patient level datasets
		Flynn RWV, MacDonald TM, Morris AD, Jung RT, Leese GP
	OC12	High frequency of abnormal GH suppression and subclinical acromegaly in a series of patients with thyrotropinsecreting pituitary adenoma
		Pramodh S, Gilbert JA, Hepburn S , Chambers S, Al-Sarraj S, McGregor A, Aylwin SJB
	OC13	Effect of dopamine agonists on prolactinomas and normal pituitary, assessed by dynamic contrast enhanced magnetic resonance imaging
		Manuchehri AM, Lowry M, Turnbull LW, Rowland-Hill C, Atkin SL
	OC14	Comparison of random growth hormone and mean growth hormone on oral glucose in patients with acromegaly
		Jayasena CNL, Wujanto C, Todd JF, Meeran K
	OC15	Prolactin secretion in the female annexin 1 knockout mouse: effects of ovariectomy and oestrogen replacement
		Cover PO, McCulley C, Buckingham JC
	OC16	Expression and function of NR5A1, NR5A2 and NR0B1 in mediating gonadotrophin-releasing hormone (GnRH) function in gonadotroph cell lines
		Mirczuk SM, Poulet B, Chand AN, Burrin JM, Fowkes RC
10.30 – 12.30		Sloane/Lineacre
		Symposium 4:
		Hormone measurements: past, present and future
		Chair: Fraser W (Liverpool)
	S17	Ligand assay - origins, present state of the art and ultimate future
		Ekins RP (London)
	S18	Steroid profiling
		Taylor N (London)
	S19	Detecting growth hormone abuse in athletes
		Strasburger CJ (Berlin, Germany)
	S20	The metabolome past, present and future
		Wheatley D (Aberdeen)
12.30 – 13.15		Osler/Long Room
		Lunch
12.30 – 13.15		Library
		Attended Posters
13.15 – 14.15		Wolfson Theatre
		Clinical Endocrine Debate:
		'This house believes that postmenopausal women benefit from oestrogen therapy'
		Chair: Bevan J (Aberdeen)
		For: Studd J (London)
		Against: Buckler H (Manchester)
14.15 – 15.15		Wolfson Theatre
		Plenary Lecture: Society for Endocrinology European Medal Lecture
		Chair: Bloom S (London)
	S4	Estrogen receptors at work in living animals
		Maggi A (Milan, Italy)
15.15 – 15.30		Osler/Long Room
		Tea
15.30 – 17.30		Wolfson Theatre
		Symposium 5:
		Evolving aspects in the HPA axis
		Chair: Trainer P (Manchester)
	S21	Clinical and genetic aspects of glucocorticoid sensitivity
		Ray D (Manchester)
	S22	Update on Cushing's of the omentum
		Tomlinson J (Birmingham)
	S23	Novel therapeutic directions in Cushing's
		Levy A (Bristol)
	S24	Carney complex, a personal perspective
		Carney J (Rochester, USA)
15.30 – 17.30		Seligman Theatre
		Oral Communications 3:
		Young Endocrinologist Session, including Basic Science Review Lecture
		Chair: Bloom S (London) & Fowkes R (London)
	OC17	Stem cells: therapeutic prospects for diabetes mellitus
		Burns C (Potters Bar)
	OC18	Functional SNPs involved in NF-kB signalling and binding pathways and their contribution to the pathogenesis of Graves' disease
		Simmonds MJ, Heward JM, Carr-Smith JD, Foxall H, Franklyn JA, Gough SCL
	OC19	Characterisation of a novel glucocorticoid-interacting protein expressed in human cancers that modulates glucocorticoid sensitivity
		Rice LM, Waters C, Garside H, Ray DW, White A
	OC20	Investigating the role of ABCA1 in the externalisation of Annexin 1 in the anterior pituitary
		Omer S, Christian HC, Morris JF
	OC21	Neuroendocrine response to ghrelin in patients with anorexia nervosa (AN)
		Miljic D, Pekic S, Djurovic M, Doknic M, Milic N, Casanueva FF, Ghatei M, Popovic V
	OC22	Antioxidants enhance the adrenocortical response to stress in the fetus
		Thakor AS, Giussani DA
	OC23	The effect of the hormonal milieu on the response of the isolated human myometrium to PGE2
		Fischer DP, Farrar D, O'Donovan P, Senior J, Marshall KM
	OC24	Bovine endometrial cells express Toll-like Receptor 4 (TLR4) and secrete prostaglandins in response to lipopolysaccharide
		Herath S, Bryant CE, Sheldon IM
15.30 – 17.30		Sloane/Lineacre
		Special Interest Group:
		Endocrinology of bone diseases
		Chair: Thakker R (Oxford)
	S36	Thyroid and bone
		Williams G (London)
	S37	Understanding the molecular basis of adverse effects of bisphosphonate drugs in the treatment of bone diseases
		Rogers M (Aberdeen)
	S38	Hormonal assays for calcitropic hormones - PTH and FGF 23
		Fraser W (Liverpool)
	S39	Vitamin D analogues: pharmacology and therapeutic uses
		Bouillon R (Leuven, Belgium)
17.30 – 18.30		Wolfson Theatre
		Shire Pharmaceuticals Ltd Satellite Facial hirsutism - the primary and secondary care interface